1-methyl-3-isobutylxanthine has been researched along with Leukemia, Myeloid in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, M | 1 |
| Hirayoshi, K | 1 |
| Okuma, M | 1 |
| Nagata, K | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and Leukemia, Myeloid
| Article | Year |
|---|---|
Enhancement of differentiation induction of mouse myelomonocytic leukemic cells by extracellular ATP.
Topics: 1-Methyl-3-isobutylxanthine; Actins; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Aden | 1994 |